
GlaxoSmithKline plc GSK
€ 42.94
0.0%
Geschäftsbericht 2025
hinzugefügt 18.04.2026
GlaxoSmithKline plc Finanzkreislauf 2011-2026 | GSK
Finanzkreislauf Jährlich GlaxoSmithKline plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 0.02 | 0.04 | 0.04 | 0.08 | 0.06 | 200 | 194 | 211 | 166 | 184 | 193 |
Alle Zahlen in GBP-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 211 | 0.02 | 104 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Edesa Biotech
EDSA
|
97.1 | $ 15.46 | - | $ 49.4 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.11 | - | $ 646 M | ||
|
Exelixis
EXEL
|
-8.32 | $ 44.42 | - | $ 12.1 B | ||
|
Fortress Biotech
FBIO
|
-74.9 | $ 2.46 | - | $ 68.6 M | ||
|
Fennec Pharmaceuticals
FENC
|
148 | $ 6.72 | - | $ 192 M | ||
|
Hutchison China MediTech Limited
HCM
|
-10.5 | $ 13.3 | - | $ 11.4 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Immuron Limited
IMRN
|
867 | $ 0.79 | - | $ 8.53 M | ||
|
INmune Bio
INMB
|
19.9 K | $ 1.54 | - | $ 38.1 M | ||
|
Ionis Pharmaceuticals
IONS
|
-556 | $ 75.25 | - | $ 12 B | ||
|
KalVista Pharmaceuticals
KALV
|
-816 | $ 26.71 | - | $ 1.44 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
257 | $ 22.35 | - | $ 3.7 B | ||
|
Kamada Ltd.
KMDA
|
163 | $ 8.21 | - | $ 260 M | ||
|
Kymera Therapeutics
KYMR
|
-46.6 | $ 82.71 | - | $ 6.99 B | ||
|
Galapagos NV
GLPG
|
67.1 | $ 28.39 | - | $ 2.69 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.27 | - | $ 6.83 B | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Mirum Pharmaceuticals
MIRM
|
70.6 | $ 105.81 | - | $ 5.31 B | ||
|
MannKind Corporation
MNKD
|
349 | $ 2.86 | - | $ 874 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 23.42 | - | $ 2.98 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K |